导航出血休克:生物标志物,疗法和临床护理中的挑战
Kenneth Meza Monge1, Caleb Rosa1, Christopher Sublette1
1Department of Surgery, Division of G.I, Trauma, and Endocrine Surgery, University of Colorado, Aurora, CO 80045, USA.
Biomedicines
|January 8, 2025
概括
出血性休克是可预防死亡的主要原因,涉及复杂的炎症和免疫抑制. 量身定制的疗法和早期干预措施,如胺酸,可以改善结果,但个性化医疗是关键.
科学领域:
- 创伤和紧急医疗医学
- 免疫学 免疫学 免疫学
- 关键护理医学 关键护理医学
背景情况:
- 在全球范围内,出血性休克是可预防死亡的重要原因.
- 根据受伤类型和严重程度,死亡率有所不同,这凸显了对细微了解的需要.
- 在出血性休克中,炎症反应通过不同的关键阶段进展.
研究的目的:
- 为了回顾出血性休克的复杂病理生理学.
- 检查炎症反应的时间演变和生物标志物的实用性.
- 为了评估基于证据的治疗性干预对于出血性休克.
主要方法:
- 关于出血性休克病理生理学的综合文献综述.
- 分析炎症级联进展和不同的阶段.
- 评估当前和研究中的治疗策略.
主要成果:
- 炎症级联包括组织损伤,内皮激活,全身炎症和免疫抑制.
- 穿透和的创伤表现出不同的炎症模式,需要量身定制的治疗.
- 控制损伤的复苏和平衡的血液产品改善了结果; 支持特兰胺酸.
结论:
- 早期的出血控制,适当的血液产品比率和及时的干预是至关重要的.
- 在生物标志物验证,治疗时间和个性化治疗实施方面仍然存在挑战.
- 未来的研究应该集中在精准医学,实时监测和新疗法上.
相关概念视频
Blood Pressure Imbalances and Circulatory Shock
746
Disorders affecting blood volume, vascular tone, or vascular function can disrupt vascular homeostasis, including conditions like hypertension, hemorrhage, and shock.
Blood Pressure: Hypertension and Hypotension
Normal blood pressure is 120/80 mm Hg. Elevated blood pressure is 120-129/under 80 mm Hg. Hypertension, warranting treatment at 130/80 mm Hg, is often asymptomatic and can lead to severe cardiovascular events, aneurysms, peripheral arterial disease, chronic renal disease, or cardiac...
Blood Pressure: Hypertension and Hypotension
Normal blood pressure is 120/80 mm Hg. Elevated blood pressure is 120-129/under 80 mm Hg. Hypertension, warranting treatment at 130/80 mm Hg, is often asymptomatic and can lead to severe cardiovascular events, aneurysms, peripheral arterial disease, chronic renal disease, or cardiac...
746
Esophageal Varices-II: Clinical Features and Management
46
Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
46
Introduction to Hemostasis
5.4K
Hemostasis is a complex physiological process that prevents excessive bleeding when a blood vessel is injured. It's crucial for maintaining the integrity of the circulatory system, as it ensures that our blood remains fluid while still within the vascular network and yet clots to prevent blood loss upon vessel injury.
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
5.4K
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
96
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
96
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
56
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
56
Disorders of Hemostasis
696
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
696


